BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease

NCT01345656 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

457

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: BAY94-8862
DRUG: BAY94-8862
DRUG: BAY94-8862
DRUG: BAY94-8862
DRUG: Placebo
DRUG: Spironolactone

Sponsor

Bayer